Kymera Therapeutics Inc. (KYMR)
NASDAQ · Healthcare
Kymera Therapeutics Inc. Total Liabilities 2019–2025
Kymera Therapeutics Inc. annual/quarterly total liabilities history from 2019 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Kymera Therapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 163.1M, a 14.56% increase year-over-year.
- Kymera Therapeutics Inc. total liabilities for 2025 were 163.1M, a 14.56% increase from 2024.
- Kymera Therapeutics Inc. total liabilities for 2024 were 142.4M, a 21.22% decrease from 2023.
- Kymera Therapeutics Inc. total liabilities for 2023 were 180.8M, a 60.01% increase from 2022.
- Kymera Therapeutics Inc. total liabilities for 2022 were 113.0M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Kymera Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $163 |
| 2024 | $142 |
| 2023 | $181 |
| 2022 | $113 |
| 2021 | $146 |
| 2020 | $203 |
| 2019 | $82 |
| Kymera Therapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $163 |
| 2024-12-31 | $142 |
| 2023-12-31 | $181 |
| 2022-12-31 | $113 |
| 2021-12-31 | $146 |
| 2020-12-31 | $203 |
| 2019-12-31 | $82 |
Kymera Therapeutics Inc. Total Liabilities — FAQ
Kymera Therapeutics Inc. (KYMR) total liabilities over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KYMR's total liabilities history?
The chart and table above show Kymera Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.